Cardio Oncology the Clinical Overlap of Cancer and Heart Disease
Management of chemotherapy-associated cardiomyopathy
Publication
, Chapter
Gilstrap, L; Harrison, M; Kimmick, GG; Nohria, A
April 11, 2017
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Gilstrap, L., Harrison, M., Kimmick, G. G., & Nohria, A. (2017). Management of chemotherapy-associated cardiomyopathy. In Cardio Oncology the Clinical Overlap of Cancer and Heart Disease (pp. 81–104). https://doi.org/10.1007/978-3-319-43096-6_4
Gilstrap, L., M. Harrison, G. G. Kimmick, and A. Nohria. “Management of chemotherapy-associated cardiomyopathy.” In Cardio Oncology the Clinical Overlap of Cancer and Heart Disease, 81–104, 2017. https://doi.org/10.1007/978-3-319-43096-6_4.
Gilstrap L, Harrison M, Kimmick GG, Nohria A. Management of chemotherapy-associated cardiomyopathy. In: Cardio Oncology the Clinical Overlap of Cancer and Heart Disease. 2017. p. 81–104.
Gilstrap, L., et al. “Management of chemotherapy-associated cardiomyopathy.” Cardio Oncology the Clinical Overlap of Cancer and Heart Disease, 2017, pp. 81–104. Scopus, doi:10.1007/978-3-319-43096-6_4.
Gilstrap L, Harrison M, Kimmick GG, Nohria A. Management of chemotherapy-associated cardiomyopathy. Cardio Oncology the Clinical Overlap of Cancer and Heart Disease. 2017. p. 81–104.